The International Myeloma Foundation (IMF) and the International Myeloma Working Group (IMWG) are set to honor the recipients of the 2025 Robert A. Kyle Achievement Award and Brian G.M. Durie Outstanding Achievement Award. The awarding ceremony will take place on June 10, 2025, at the 16th Annual International Myeloma Working Group (IMWG) Summit in Milano, Italy.

Each year, the Robert A. Kyle Lifetime Achievement and Brian G.M. Durie Outstanding Achievement Awards recognize individuals who have made significant contributions to myeloma research. This year's awardees include Dr. Sagar Lonial and Dr. Sonja Zweegman.

Dr. Sagar Lonial - 2025 Robert A. Kyle Lifetime Achievement Awardee

Dr. Sagar Lonial is the Chair and Professor of the Department of Hematology and Medical Oncology at Emory University School of Medicine. He is a renowned authority in multiple myeloma treatment and research, having authored over 400 papers and abstracts. Dr. Lonial's work focuses on immunotherapy, cancer, and developing novel treatment strategies for myeloma and lymphoma.

His accolades include the Celgene Young Investigator Award and the COMy Multiple Myeloma Excellence Award for Clinical Science. Dr. Lonial expressed his pride in receiving the prestigious award and acknowledged the efforts of his team in advancing myeloma patient outcomes.

Dr. Sonja Zweegman - 2025 Brian G.M. Durie Outstanding Achievement Awardee

Dr. Sonja Zweegman, Head of the Department of Hematology at Amsterdam UMC, is recognized for her work in optimizing myeloma treatment, especially for vulnerable populations. She leads translational research efforts focused on immune-based therapies and innovative treatment strategies for resistant disease.

Dr. Zweegman's commitment to improving patient quality of life aligns with the IMF's vision of enhancing myeloma patient care. Her dedication to clinical research and patient advocacy makes her a deserving recipient of the Brian G.M. Durie Outstanding Achievement Award.